Shares in Sky Group per chance? ;-)Study from South Africa finds two doses of Pfizer-Biontech vaccine gives 70% protection against hospitalisation & 33% protection against infection
For more on this and other news visit https://t.co/8OWd2TvLrt
You have different standards to me then. I think it's very alarming that Pfizer (the most effective of all vaccines) will leave a very significant number of elderly people exposed to hospitalisation.So, if I understand correctly, even with waning immunity, two doses would still appear to offer more protection than the average flu vaccine. Great news.
So 3 jabs will really bump up protection?Study from South Africa finds two doses of Pfizer-Biontech vaccine gives 70% protection against hospitalisation & 33% protection against infection
For more on this and other news visit https://t.co/8OWd2TvLrt
The regionality of this virus is really difficult to understand. We can see that most of London and the South East for example is bearing the brunt of Omicron yet the rest of the country is probably still wholly tackling Delta.
I'd imagine the same thing is happening in SA but weren't they struggling with Beta and not Delta? It's really complicated and I can only see that they're similarly probably fighting different variants in different areas. Coupled with low vaccination rates it's pretty obvious that deaths are inevitable with either variant.
A more interesting thing is that SA has continually remained on the UK Red List in the past not because of variants but because of low vaccination rates, poor reporting and probable poor sequencing which doesn't bode too well really.



Suppose they don't have data on Astra ZenecaStudy from South Africa finds two doses of Pfizer-Biontech vaccine gives 70% protection against hospitalisation & 33% protection against infection
For more on this and other news visit https://t.co/8OWd2TvLrt
You talk about holding up but 67% effectiveness (after 2 Pfizer jabs) against hospitalisation for over 60s is not holding up in my book (and it's lower still for older age groups). And AZ will be worse
It's a good job the boosters work. That data underlines why it's so important to get boosters, particularly for the elderly
Absolutely.So 3 jabs will really bump up protection?
It still offers significant protection against a mutated variant, no? And I agree that it’s important that older people are prioritised for a booster around the world.You have different standards to me then. I think it's very alarming that Pfizer (the most effective of all vaccines) will leave a very significant number of elderly people exposed to hospitalisation.
This is going to be an absolute disaster for countries with large elderly populations who don't have booster programs, or whose booster programs are not well advanced.p
Remember we are facing an absolute avalanche of cases. It's now absolutely crucial that all elderly people get a booster.
they stopped using AZ back in Feb/March and sold there stock to other countries as it had less efficacy against Beta which was around a lot back then over there.Suppose they don't have data on Astra Zeneca
60-69: 67%It still offers significant protection against a mutated variant, no? And I agree that it’s important that older people are prioritised for a booster around the world.
So 3 jabs will really bump up protection?
60-69: 67%
70-79: 59%
Our data for an old UK population who got vaccinated by AZ a lot earlier will be worse imo. Use LFTs before visiting people you love and get boosted.
This seriously is time to be very careful. The one bonus we have is that the booster vaccination campaign.
60-69: 67%
70-79: 59%
Our data for an old UK population who got vaccinated by AZ a lot earlier will be worse imo. Use LFTs before visiting people you love and get boosted.
This seriously is time to be very careful. The one bonus we have is that the booster vaccination campaign.
Why are you assuming AZ would be worse? I remember seeing some info that AZ (adenovirus vector vaccines) actually produced more robust T-cells than the mRNA jabs and so if this is correct, we may actually have played a blinder by injecting our oldies with AZ. There isn’t enough data to make such a statement in reality other than perceiving AZ to be inferior.
(I’m under 40 but had 2 x AZ + Pfizer booster)
![]()
T-cell ‘training grounds’ behind robust immune system response seen in adenovirus vaccines | University of Oxford
Adenovirus vaccine vectors, such as the ChAdOx1 nCov-19 construct which has risen to prominence as a major vaccine for COVID-19, may generate robust long-term immune system responses, according to scientists from the Universities of Oxford and the Cantonal Hospital St.Gallen, Switzerland.www.ox.ac.uk
![]()
Moderna or Novavax after AstraZeneca jab confers high Covid immunity, study finds
Finding is good news for lower-income countries that have not yet completed their primary vaccination campaignsamp.theguardian.com
She's certainly very bullish about this isn't she.The evidence on Omicron coming out of South Africa continues to look encouraging.
The head of the South African Medical Association has just said the variant still seems to be causing milder symptoms than the previously dominant Delta virus.
Dr Angelique Coetzee told the Science and Technology Committee that even hospitalised patients needed care for half as long – and were less likely to need oxygen.
We can’t trust the BBC reporting though as they said With, not Of, yesterday.